Molecular characterization of chordoma xenografts generated from a novel primary chordoma cell source and two chordoma cell lines.

dc.contributor.author

Karikari, Isaac O

dc.contributor.author

Gilchrist, Christopher L

dc.contributor.author

Jing, Liufang

dc.contributor.author

Alcorta, David A

dc.contributor.author

Chen, Jun

dc.contributor.author

Richardson, William J

dc.contributor.author

Gabr, Mostafa A

dc.contributor.author

Bell, Richard D

dc.contributor.author

Kelley, Michael J

dc.contributor.author

Bagley, Carlos A

dc.contributor.author

Setton, Lori A

dc.coverage.spatial

United States

dc.date.accessioned

2014-06-11T17:45:14Z

dc.date.issued

2014-09

dc.description.abstract

OBJECT: Chordoma cells can generate solid-like tumors in xenograft models that express some molecular characteristics of the parent tumor, including positivity for brachyury and cytokeratins. However, there is a dearth of molecular markers that relate to chordoma tumor growth, as well as the cell lines needed to advance treatment. The objective in this study was to isolate a novel primary chordoma cell source and analyze the characteristics of tumor growth in a mouse xenograft model for comparison with the established U-CH1 and U-CH2b cell lines. METHODS: Primary cells from a sacral chordoma, called "DVC-4," were cultured alongside U-CH1 and U-CH2b cells for more than 20 passages and characterized for expression of CD24 and brachyury. While brachyury is believed essential for driving tumor formation, CD24 is associated with healthy nucleus pulposus cells. Each cell type was subcutaneously implanted in NOD/SCID/IL2Rγ(null) mice. The percentage of solid tumors formed, time to maximum tumor size, and immunostaining scores for CD24 and brachyury (intensity scores of 0-3, heterogeneity scores of 0-1) were reported and evaluated to test differences across groups. RESULTS: The DVC-4 cells retained chordoma-like morphology in culture and exhibited CD24 and brachyury expression profiles in vitro that were similar to those for U-CH1 and U-CH2b. Both U-CH1 and DVC-4 cells grew tumors at rates that were faster than those for U-CH2b cells. Gross tumor developed at nearly every site (95%) injected with U-CH1 and at most sites (75%) injected with DVC-4. In contrast, U-CH2b cells produced grossly visible tumors in less than 50% of injected sites. Brachyury staining was similar among tumors derived from all 3 cell types and was intensely positive (scores of 2-3) in a majority of tissue sections. In contrast, differences in the pattern and intensity of staining for CD24 were noted among the 3 types of cell-derived tumors (p < 0.05, chi-square test), with evidence of intense and uniform staining in a majority of U-CH1 tumor sections (score of 3) and more than half of the DVC-4 tumor sections (scores of 2-3). In contrast, a majority of sections from U-CH2b cells stained modestly for CD24 (scores of 1-2) with a predominantly heterogeneous staining pattern. CONCLUSIONS: This is the first report on xenografts generated from U-CH2b cells in which a low tumorigenicity was discovered despite evidence of chordoma-like characteristics in vitro. For tumors derived from a primary chordoma cell and U-CH1 cell line, similarly intense staining for CD24 was observed, which may correspond to their similar potential to grow tumors. In contrast, U-CH2b tumors stained less intensely for CD24. These results emphasize that many markers, including CD24, may be useful in distinguishing among chordoma cell types and their tumorigenicity in vivo.

dc.identifier

http://www.ncbi.nlm.nih.gov/pubmed/24905390

dc.identifier.eissn

1547-5646

dc.identifier.uri

https://hdl.handle.net/10161/8887

dc.language

eng

dc.publisher

Journal of Neurosurgery Publishing Group (JNSPG)

dc.relation.ispartof

J Neurosurg Spine

dc.relation.isversionof

10.3171/2014.4.SPINE13262

dc.subject

BSA = bovine serum albumin

dc.subject

CD24

dc.subject

FBS = fetal bovine serum

dc.subject

FITC = fluorescein isothiocyanate

dc.subject

IMDM = Iscove's modified Dulbecco's medium

dc.subject

MFI = mean fluorescence intensity

dc.subject

NSG = NOD/SCID/IL2Rγnull

dc.subject

PBS = phosphate-buffered saline

dc.subject

PCR = polymerase chain reaction

dc.subject

U-CH1

dc.subject

U-CH2b

dc.subject

brachyury

dc.subject

chordoma

dc.subject

oncology

dc.subject

xenograft

dc.subject

Aged

dc.subject

Animals

dc.subject

Antigens, CD24

dc.subject

Biomarkers, Tumor

dc.subject

Cell Line, Tumor

dc.subject

Chordoma

dc.subject

Disease Models, Animal

dc.subject

Fetal Proteins

dc.subject

Flow Cytometry

dc.subject

Heterografts

dc.subject

Humans

dc.subject

Immunohistochemistry

dc.subject

Keratins

dc.subject

Male

dc.subject

Mice

dc.subject

Polymerase Chain Reaction

dc.subject

Sacrum

dc.subject

T-Box Domain Proteins

dc.subject

Tumor Cells, Cultured

dc.title

Molecular characterization of chordoma xenografts generated from a novel primary chordoma cell source and two chordoma cell lines.

dc.type

Journal article

duke.contributor.orcid

Gabr, Mostafa A|0000-0003-2058-2098

duke.contributor.orcid

Kelley, Michael J|0000-0001-9523-6080

pubs.author-url

http://www.ncbi.nlm.nih.gov/pubmed/24905390

pubs.begin-page

386

pubs.end-page

393

pubs.issue

3

pubs.organisational-group

Biomedical Engineering

pubs.organisational-group

Clinical Science Departments

pubs.organisational-group

Duke

pubs.organisational-group

Duke Cancer Institute

pubs.organisational-group

Duke Institute for Brain Sciences

pubs.organisational-group

Faculty

pubs.organisational-group

Institutes and Centers

pubs.organisational-group

Institutes and Provost's Academic Units

pubs.organisational-group

Medicine

pubs.organisational-group

Medicine, Medical Oncology

pubs.organisational-group

Neurosurgery

pubs.organisational-group

Orthopaedics

pubs.organisational-group

Pratt School of Engineering

pubs.organisational-group

School of Medicine

pubs.organisational-group

University Institutes and Centers

pubs.publication-status

Published

pubs.volume

21

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
karikari_final.pdf
Size:
5.94 MB
Format:
Adobe Portable Document Format
Description:
Accepted version